{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,21]],"date-time":"2026-11-21T06:15:23Z","timestamp":1795241723208,"version":"4.10.3"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01-AG062109"],"award-info":[{"award-number":["R01-AG062109"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01-AG083735"],"award-info":[{"award-number":["R01-AG083735"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01-HL159620"],"award-info":[{"award-number":["R01-HL159620"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-62590-4","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T13:37:04Z","timestamp":1754919424000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["AI-driven fusion of multimodal data for Alzheimer\u2019s disease biomarker assessment"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2689-0259","authenticated-orcid":false,"given":"Varuna H.","family":"Jasodanand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9547-7638","authenticated-orcid":false,"given":"Sahana S.","family":"Kowshik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6850-7370","authenticated-orcid":false,"given":"Shreyas","family":"Puducheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhoda","family":"Au","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5312-8644","authenticated-orcid":false,"given":"Vijaya B.","family":"Kolachalama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"62590_CR1","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","volume":"14","author":"C Jack","year":"2018","unstructured":"Jack, C. et al. NIA-AA Research framework: Toward a biological definition of Alzheimer\u2019s disease. Alzheimer\u2019s Dementia 14, 535\u2013562 (2018).","journal-title":"Alzheimer\u2019s Dementia"},{"key":"62590_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s13195-023-01314-6","volume":"15","author":"B Dubois","year":"2023","unstructured":"Dubois, B., Von Arnim, C., Burnie, N., Bozeat, S. & Cummings, J. Biomarkers in Alzheimer\u2019s disease: Role in early and differential diagnosis and recognition of atypical variants. Alzheimer\u2019s Res. Ther. 15, 175 (2023).","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"62590_CR3","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1056\/NEJMoa2310168","volume":"390","author":"J Jia","year":"2024","unstructured":"Jia, J. et al. Biomarker changes during 20 years preceding Alzheimer\u2019s disease. N. Engl. J. Med. 390, 712\u2013722 (2024).","journal-title":"N. Engl. J. Med."},{"key":"62590_CR4","doi-asserted-by":"publisher","first-page":"5143","DOI":"10.1002\/alz.13859","volume":"20","author":"CJr Jack","year":"2024","unstructured":"Jack, C. Jr. et al. Revised criteria for diagnosis and staging of Alzheimer\u2019s disease: Alzheimer\u2019s Association Workgroup. Alzheimer\u2019s Dementia 20, 5143\u20135169 (2024).","journal-title":"Alzheimer\u2019s Dementia"},{"key":"62590_CR5","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1001\/jama.2019.2000","volume":"321","author":"G Rabinovici","year":"2019","unstructured":"Rabinovici, G. et al. Association of amyloid positron emission tomography with subsequent change in clinical management among medicare beneficiaries with mild cognitive impairment or dementia. JAMA 321, 1286\u20131294 (2019).","journal-title":"JAMA"},{"key":"62590_CR6","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"J Sims","year":"2023","unstructured":"Sims, J. et al. Donanemab in early symptomatic Alzheimer disease: The TRAILBLAZER-ALZ 2 randomized clinical trial. JAMA 330, 512\u2013527 (2023).","journal-title":"JAMA"},{"key":"62590_CR7","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"C Dyck","year":"2023","unstructured":"Dyck, C. et al. Lecanemab in early Alzheimer\u2019s disease. N. Engl. J. Med. 388, 9\u201321 (2023).","journal-title":"N. Engl. J. Med."},{"key":"62590_CR8","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1056\/NEJMoa2305032","volume":"389","author":"R Sperling","year":"2023","unstructured":"Sperling, R. et al. Aisen trial of solanezumab in preclinical Alzheimer\u2019s disease. N. Engl. J. Med. 389, 1096\u20131107 (2023).","journal-title":"N. Engl. J. Med."},{"key":"62590_CR9","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1002\/alz.12450","volume":"18","author":"J Cummings","year":"2022","unstructured":"Cummings, J., Goldman, D., Simmons-Stern, N. & Ponton, E. The costs of developing treatments for Alzheimer\u2019s disease: A retrospective exploration. Alzheimer\u2019s Dementia 18, 469\u2013477 (2022).","journal-title":"Alzheimer\u2019s Dementia"},{"key":"62590_CR10","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1001\/jamaneurol.2024.1612","volume":"81","author":"C Groot","year":"2024","unstructured":"Groot, C. et al. Tau positron emission tomography for predicting dementia in individuals with mild cognitive impairment. JAMA Neurol. 81, 845\u2013856 (2024).","journal-title":"JAMA Neurol."},{"key":"62590_CR11","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S1474-4422(22)00168-5","volume":"21","author":"R Ossenkoppele","year":"2022","unstructured":"Ossenkoppele, R., Van der Kant, R. & Hansson, O. Tau biomarkers in Alzheimer\u2019s disease: towards implementation in clinical practice and trials. Lancet Neurol. 21, 726\u2013734 (2022).","journal-title":"Lancet Neurol."},{"key":"62590_CR12","first-page":"e12385","volume":"9","author":"J Cummings","year":"2023","unstructured":"Cummings, J. et al. Alzheimer\u2019s disease drug development pipeline: 2023. Alzheimer\u2019s Dementia 9, e12385 (2023).","journal-title":"Alzheimer\u2019s Dementia"},{"key":"62590_CR13","doi-asserted-by":"publisher","first-page":"e047539","DOI":"10.1002\/alz.047539","volume":"16","author":"J Rodriguez","year":"2020","unstructured":"Rodriguez, J. et al. Plasma p-tau181 accurately predicts Alzheimer\u2019s disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline. Alzheimer\u2019s Dementia 16, e047539 (2020).","journal-title":"Alzheimer\u2019s Dementia"},{"key":"62590_CR14","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1001\/jamaneurol.2023.5319","volume":"81","author":"N Ashton","year":"2024","unstructured":"Ashton, N. et al. Diagnostic accuracy of a plasma phosphorylated Tau 217 immunoassay for Alzheimer disease pathology. JAMA Neurol. 81, 255\u2013263 (2024).","journal-title":"JAMA Neurol."},{"key":"62590_CR15","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1001\/jamaneurol.2019.1632","volume":"76","author":"S Palmqvist","year":"2019","unstructured":"Palmqvist, S. et al. Performance of fully automated plasma assays as screening tests for Alzheimer disease-related \u03b2-amyloid status. JAMA Neurol. 76, 1060\u20131069 (2019).","journal-title":"JAMA Neurol."},{"key":"62590_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-021-01709-9","volume":"11","author":"X Shen","year":"2021","unstructured":"Shen, X. et al. Plasma phosphorylated-Tau181 as a predictive biomarker for Alzheimer\u2019s amyloid, Tau and FDG PET status.Transl. Psychiatry 11, 585 (2021).","journal-title":"Transl. Psychiatry"},{"key":"62590_CR17","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/s41591-021-01309-6","volume":"27","author":"J Vogel","year":"2021","unstructured":"Vogel, J. et al. Four distinct trajectories of Tau deposition identified in Alzheimer\u2019s disease.Nat. Med. 27, 871\u2013881 (2021).","journal-title":"Nat. Med."},{"key":"62590_CR18","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1001\/jamaneurol.2022.0676","volume":"79","author":"C Young","year":"2022","unstructured":"Young, C. et al.Divergent cortical tau positron emission tomography patterns among patients with preclinical Alzheimer disease. JAMA Neurol. 79, 592\u2013603 (2022).","journal-title":"JAMA Neurol."},{"key":"62590_CR19","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1038\/s41591-022-01822-2","volume":"28","author":"M Mielke","year":"2022","unstructured":"Mielke, M. et al. Performance of plasma phosphorylated tau 181 and 217 in the community. Nat. Med. 28, 1398\u20131405 (2022).","journal-title":"Nat. Med."},{"key":"62590_CR20","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41582-024-00989-1","volume":"20","author":"M Mielke","year":"2024","unstructured":"Mielke, M. & Fowler, N. Alzheimer disease blood biomarkers: Considerations for population-level use. Nat. Rev. Neurol. 20, 495\u2013504 (2024).","journal-title":"Nat. Rev. Neurol."},{"key":"62590_CR21","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jalz.2018.08.014","volume":"15","author":"S Palmqvist","year":"2019","unstructured":"Palmqvist, S. et al. Accurate risk estimation of \u03b2-amyloid positivity to identify prodromal Alzheimer\u2019s disease: Cross-validation study of practical algorithms. Alzheimer\u2019s Dementia 15, 194\u2013204 (2019).","journal-title":"Alzheimer\u2019s Dementia"},{"key":"62590_CR22","doi-asserted-by":"publisher","first-page":"fcab008","DOI":"10.1093\/braincomms\/fcab008","volume":"3","author":"D Tosun","year":"2021","unstructured":"Tosun, D. et al. Detection of \u03b2-amyloid positivity in Alzheimer\u2019s disease neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers. Brain Commun. 3, fcab008 (2021).","journal-title":"Brain Commun."},{"key":"62590_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3233\/JAD-201092","volume":"80","author":"S Kang","year":"2021","unstructured":"Kang, S. et al. Machine learning for the prediction of amyloid positivity in amnestic mild cognitive impairment. J. Alzheimer\u2019s Disease 80, 143\u2013157 (2021). PMID: 33523003.","journal-title":"J. Alzheimer\u2019s Disease"},{"key":"62590_CR24","doi-asserted-by":"crossref","unstructured":"Pekkala, T. et al. Detecting amyloid positivity in elderly with increased risk of cognitive decline. Front. Aging Neurosci. 12, 228 (2020).","DOI":"10.3389\/fnagi.2020.00228"},{"key":"62590_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-83911-9","volume":"11","author":"G Shan","year":"2021","unstructured":"Shan, G., Bernick, C., Caldwell, J. & Ritter, A. Machine learning methods to predict amyloid positivity using domain scores from cognitive tests. Sci. Rep. 11, 4822 (2021).","journal-title":"Sci. Rep."},{"key":"62590_CR26","doi-asserted-by":"publisher","first-page":"e2425","DOI":"10.1212\/WNL.0000000000200553","volume":"98","author":"K Petersen","year":"2022","unstructured":"Petersen, K. et al. Predicting amyloid positivity in cognitively unimpaired older adults. Neurology 98, e2425\u2013e2435 (2022).","journal-title":"Neurology"},{"key":"62590_CR27","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3233\/JAD-220812","volume":"91","author":"J Wu","year":"2023","unstructured":"Wu, J. et al. Improved prediction of amyloid-\u03b2 and tau burden using hippocampal surface multivariate morphometry statistics and sparse coding. J. Alzheimer\u2019s Disease 91, 637\u2013651 (2023). PMID: 36463452.","journal-title":"J. Alzheimer\u2019s Disease"},{"key":"62590_CR28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13195-024-01415-w","volume":"16","author":"E Moradi","year":"2024","unstructured":"Moradi, E. et al. For the Alzheimer\u2019s disease neuroimaging initiative machine learning prediction of future amyloid beta positivity in amyloid-negative individuals. Alzheimer\u2019s Res.Ther 16, 46 (2024).","journal-title":"Alzheimer\u2019s Res.Ther"},{"key":"62590_CR29","doi-asserted-by":"publisher","first-page":"e14600","DOI":"10.1002\/alz.14600","volume":"21","author":"L Karlsson","year":"2025","unstructured":"Karlsson, L. et al. Machine learning prediction of tau-PET in Alzheimer\u2019s disease using plasma, MRI, and clinical data. Alzheimer\u2019s Dementia 21, e14600 (2025).","journal-title":"Alzheimer\u2019s Dementia"},{"key":"62590_CR30","first-page":"e12454","volume":"15","author":"V Villemagne","year":"2023","unstructured":"Villemagne, V. et al. CenTauR: Toward a universal scale and masks for standardizing tau imaging studies.Alzheimer\u2019s Dementia 15, e12454 (2023).","journal-title":"Alzheimer\u2019s Dementia"},{"key":"62590_CR31","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","volume":"23","author":"M Busche","year":"2020","unstructured":"Busche, M. & Hyman, B. Synergy between amyloid-\u03b2 and tau in Alzheimer\u2019s Disease. Nat. Neurosci. 23, 1183\u20131193 (2020).","journal-title":"Nat. Neurosci."},{"key":"62590_CR32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239\u2013259 (1991).","journal-title":"Acta Neuropathol."},{"key":"62590_CR33","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1038\/s41591-024-03118-z","volume":"30","author":"C Xue","year":"2024","unstructured":"Xue, C. et al. AI-based differential diagnosis of dementia etiologies on multimodal data. Nat. Med. 30, 2977\u20132989 (2024).","journal-title":"Nat. Med."},{"key":"62590_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-009-0612-2","volume":"119","author":"I Mackenzie","year":"2010","unstructured":"Mackenzie, I. et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: An update. Acta Neuropathol. 119, 1\u20134 (2010).","journal-title":"Acta Neuropathol."},{"key":"62590_CR35","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/bpa.12248","volume":"25","author":"A McKee","year":"2015","unstructured":"McKee, A., Stein, T., Kiernan, P. & Alvarez, V. The neuropathology of chronic traumatic encephalopathy. Brain Pathol. 25, 350\u2013364 (2015).","journal-title":"Brain Pathol."},{"key":"62590_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13195-019-0470-7","volume":"11","author":"R Tsai","year":"2019","unstructured":"Tsai, R. et al. 18F-flortaucipir (AV-1451) Tau PET in frontotemporal dementia syndromes. Alzheimer\u2019s Res. Ther. 11, 13 (2019).","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"62590_CR37","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1056\/NEJMoa1900757","volume":"380","author":"R Stern","year":"2019","unstructured":"Stern, R. et al. Reiman tau positron-emission tomography in former national football league players. N. Engl. J. Med. 380, 1716\u20131725 (2019).","journal-title":"N. Engl. J. Med."},{"key":"62590_CR38","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1038\/s41591-022-02049-x","volume":"28","author":"R Ossenkoppele","year":"2022","unstructured":"Ossenkoppele, R. et al. Amyloid and tau PET-positive cognitively unimpaired individuals are at high risk for future cognitive decline. Nat. Med. 28, 2381\u20132387 (2022).","journal-title":"Nat. Med."},{"key":"62590_CR39","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1093\/brain\/awac299","volume":"146","author":"P Insel","year":"2022","unstructured":"Insel, P. et al. Tau positron emission tomography in preclinical Alzheimer\u2019s disease. Brain 146, 700\u2013711 (2022).","journal-title":"Brain"},{"key":"62590_CR40","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1212\/WNL.0000000000009058","volume":"94","author":"D Ferreira","year":"2020","unstructured":"Ferreira, D., Nordberg, A. & Westman, E. Biological subtypes of Alzheimer disease. Neurology 94, 436\u2013448 (2020).","journal-title":"Neurology"},{"key":"62590_CR41","doi-asserted-by":"publisher","first-page":"228fs13","DOI":"10.1126\/scitranslmed.3007941","volume":"6","author":"R Sperling","year":"2014","unstructured":"Sperling, R. et al. The A4 study: Stopping AD before symptoms begin? Sci. Transl. Med. 6, 228fs13\u2013228fs13 (2014).","journal-title":"Sci. Transl. Med."},{"key":"62590_CR42","unstructured":"Beekly, D. et al. The national Alzheimer\u2019s coordinating center (NACC) database: An Alzheimer disease database. Alzheimer Dis. Assoc. Disord. 18, 270\u2013277 (2004)."},{"key":"62590_CR43","doi-asserted-by":"publisher","unstructured":"LaMontagne, P. et al. OASIS-3: Longitudinal neuroimaging, clinical, and cognitive dataset for normal aging and Alzheimer disease. Preprint at https:\/\/doi.org\/10.1101\/2019.12.13.19014902 (2019).","DOI":"10.1101\/2019.12.13.19014902"},{"key":"62590_CR44","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1017\/S1041610209009405","volume":"21","author":"K Ellis","year":"2009","unstructured":"Ellis, K. et al. The Australian imaging, biomarkers and lifestyle (AIBL) study of aging: Methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer\u2019s disease. Int. Psychogeriatr. 21, 672\u2013687 (2009).","journal-title":"Int. Psychogeriatr."},{"key":"62590_CR45","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/S0140-6736(13)61752-3","volume":"383","author":"S Mahmood","year":"2014","unstructured":"Mahmood, S., Levy, D., Vasan, R. & Wang, T. The framingham heart study and the epidemiology of cardiovascular disease: A historical perspective. Lancet 383, 999\u20131008 (2014).","journal-title":"Lancet"},{"key":"62590_CR46","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1212\/WNL.0b013e3181cb3e25","volume":"74","author":"R Petersen","year":"2010","unstructured":"Petersen, R. et al. Alzheimer\u2019s disease neuroimaging initiative (ADNI). Neurology 74, 201\u2013209 (2010).","journal-title":"Neurology"},{"key":"62590_CR47","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.neuroimage.2015.03.069","volume":"144","author":"A Dagley","year":"2017","unstructured":"Dagley, A. et al. Harvard aging brain study: Dataset and accessibility. NeuroImage 144, 255\u2013258 (2017).","journal-title":"NeuroImage"},{"key":"62590_CR48","doi-asserted-by":"crossref","unstructured":"Klunk, W. et al. The centiloid project: Standardizing quantitative amyloid plaque estimation by PET. Alzheimer\u2019s Dementia 11, 1\u201315.e4 (2015).","DOI":"10.1016\/j.jalz.2014.07.003"},{"key":"62590_CR49","doi-asserted-by":"publisher","first-page":"eabc0655","DOI":"10.1126\/scitranslmed.abc0655","volume":"13","author":"J Sanchez","year":"2021","unstructured":"Sanchez, J. et al. Johnson The cortical origin and initial spread of medial temporal tauopathy in Alzheimer\u2019s disease assessed with positron emission tomography. Sci. Transl. Med. 13, eabc0655 (2021).","journal-title":"Sci. Transl. Med."},{"key":"62590_CR50","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1002\/alz.13731","volume":"20","author":"C Young","year":"2024","unstructured":"Young, C. et al. Speech patterns during memory recall relates to early tau burden across adulthood. Alzheimer\u2019s Dementia 20, 2552\u20132563 (2024).","journal-title":"Alzheimer\u2019s Dementia"},{"key":"62590_CR51","doi-asserted-by":"publisher","first-page":"e14378","DOI":"10.1002\/alz.14378","volume":"21","author":"S Landau","year":"2025","unstructured":"Landau, S. et al. Positron emission tomography harmonization in the Alzheimer\u2019s Disease Neuroimaging Initiative: A scalable and rigorous approach to multisite amyloid and tau quantification. Alzheimer\u2019s Dementia 21, e14378 (2025).","journal-title":"Alzheimer\u2019s Dementia"},{"key":"62590_CR52","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/ana.25395","volume":"85","author":"R Sperling","year":"2019","unstructured":"Sperling, R. et al. The impact of amyloid-beta and tau on prospective cognitive decline in older individuals. Annal. Neurol. 85, 181\u2013193 (2019).","journal-title":"Annal. Neurol."},{"key":"62590_CR53","doi-asserted-by":"publisher","first-page":"172","DOI":"10.2967\/jnumed.121.262464","volume":"63","author":"F Orlhac","year":"2022","unstructured":"Orlhac, F. et al. A guide to ComBat harmonization ofimaging biomarkers in multicenter studies. J. Nucl. Med. 63, 172\u2013179 (2022).","journal-title":"J. Nucl. Med."},{"key":"62590_CR54","doi-asserted-by":"publisher","first-page":"117012","DOI":"10.1016\/j.neuroimage.2020.117012","volume":"219","author":"L Henschel","year":"2020","unstructured":"Henschel, L. et al. FastSurfer - A fast and accurate deep learning based neuroimaging pipeline. NeuroImage 219, 117012 (2020).","journal-title":"NeuroImage"},{"key":"62590_CR55","doi-asserted-by":"crossref","unstructured":"Hatamizadeh, A. et al. Swin UNETR: Swin transformers for semantic segmentation of brain tumors in MRI images. In: Brainlesion: Glioma, Multiple Sclerosis, Stroke and Traumatic Brain Injuries. BrainLes 2021. Lecture Notes in Computer Science (eds Crimi, A. & Bakas, S.) vol 12962 (Springer, Cham, 2022).","DOI":"10.1007\/978-3-031-08999-2_22"},{"key":"62590_CR56","doi-asserted-by":"crossref","unstructured":"Tang, Y. et al. Self-supervised pre-training of swin transformers for 3D medical image analysis. In Proc. IEEE\/CVF Conference On Computer Vision And Pattern Recognition (CVPR). (2022).","DOI":"10.1109\/CVPR52688.2022.02007"},{"key":"62590_CR57","doi-asserted-by":"crossref","unstructured":"Lin, T., Goyal, P., Girshick, R., He, K. & Doll\u00e1r, P. Focal Loss for Dense Object Detection. In Proc. IEEE International Conference On Computer Vision (ICCV). (2017).","DOI":"10.1109\/ICCV.2017.324"},{"key":"62590_CR58","unstructured":"Loshchilov, I. & Hutter, F. Decoupled weight decay regularization. In International Conference on Learning Representations (2019)."},{"key":"62590_CR59","unstructured":"Lundberg, S. & Lee, S. A Unified approach to interpreting model predictions. In Proc. 31st International Conference on Neural Information Processing Systems, 4768\u20134777 (Curran Associates Inc., 2017)."},{"key":"62590_CR60","unstructured":"Mitchell, R., Cooper, J., Frank, E. & Holmes, G. Sampling permutations for Shapley value estimation. J. Mach. Learn. Res. 23, 1\u201346 (2022)."},{"key":"62590_CR61","unstructured":"Dorogush, A., Ershov, V. & Gulin, A. CatBoost: gradient boosting with categorical features support. In Proc. 32nd International Conference on Neural Information Processing Systems, 6639\u20136649 (Curran Associates Inc., 2018)."},{"key":"62590_CR62","doi-asserted-by":"crossref","unstructured":"Cover, T. & Thomas, J. Elements of Information Theory. (Wiley-Interscience, 2006).","DOI":"10.1002\/047174882X"},{"key":"62590_CR63","first-page":"583","volume":"3","author":"A Strehl","year":"2003","unstructured":"Strehl, A. & Ghosh, J. Cluster ensembles \u2014 a knowledge reuse framework for combining multiple partitions. J. Mach. Learn. Res. 3, 583\u2013617 (2003).","journal-title":"J. Mach. Learn. Res."},{"key":"62590_CR64","doi-asserted-by":"publisher","first-page":"P09008","DOI":"10.1088\/1742-5468\/2005\/09\/P09008","volume":"2005","author":"L Danon","year":"2005","unstructured":"Danon, L., D\u00edaz-Guilera, A., Duch, J. & Arenas, A. Comparing community structure identification. J. Stat. Mech. Theory Exp. and J. Stat. Mech. 2005, P09008 (2005).","journal-title":"J. Stat. Mech. Theory Exp. and J. Stat. Mech."},{"key":"62590_CR65","doi-asserted-by":"publisher","first-page":"10008","DOI":"10.1088\/1742-5468\/2008\/10\/P10008","volume":"2008","author":"V Blondel","year":"2008","unstructured":"Blondel, V., Guillaume, J., Lambiotte, R. & Lefebvre, E. Fast unfolding of communities in large networks. J. Stat. Mech. Theory Exp. 2008, 10008 (2008).","journal-title":"J. Stat. Mech. Theory Exp."},{"key":"62590_CR66","first-page":"2837","volume":"11","author":"N Vinh","year":"2010","unstructured":"Vinh, N., Epps, J. & Bailey, J. Information theoretic measures for clusterings comparison: Variants, properties, normalization and correction for chance. J. Mach. Learn. Res. 11, 2837\u20132854 (2010).","journal-title":"J. Mach. Learn. Res."},{"key":"62590_CR67","first-page":"1","volume":"17","author":"S Romano","year":"2016","unstructured":"Romano, S., Vinh, N., Bailey, J. & Verspoor, K. Adjusting for chance clustering comparison measures. J. Mach. Learn. Res. 17, 1\u201332 (2016).","journal-title":"J. Mach. Learn. Res."},{"key":"62590_CR68","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1080\/01621459.1990.10474929","volume":"85","author":"W Welch","year":"1990","unstructured":"Welch, W. Construction of permutation tests. J. Am. Stat. Assoc. 85, 693\u2013698 (1990).","journal-title":"J. Am. Stat. Assoc."},{"key":"62590_CR69","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.neuroimage.2018.05.070","volume":"178","author":"A Alexander-Bloch","year":"2018","unstructured":"Alexander-Bloch, A. et al. On testing for spatial correspondence between maps of human brain structure and function. NeuroImage 178, 540\u2013551 (2018).","journal-title":"NeuroImage"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62590-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62590-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62590-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:30:26Z","timestamp":1757377826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-62590-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["62590"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-62590-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.03.12.25323862","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"12 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"V.B.K. is a co-founder and equity holder of DeepPath Inc. and CogniScreen, Inc. He also serves on the scientific advisory board of Altoida Inc. R.A. is a scientific advisor to Signant Health and NovoNordisk. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7407"}}